Cargando…
L61H46 Shows Potent Efficacy Against Human Pancreatic Cancer Through Inhibiting STAT3 Pathway [Erratum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935021/ https://www.ncbi.nlm.nih.gov/pubmed/31920378 http://dx.doi.org/10.2147/CMAR.S240955 |
Ejemplares similares
-
L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway
por: Bai, Encheng, et al.
Publicado: (2018) -
Erratum: Vol. 68, No. 46
Publicado: (2020) -
Erratum: Vol. 69, No. 46
Publicado: (2020) -
Erratum: Vol. 71, No. 46
Publicado: (2023) -
Erratum to: hCLP46 increases Smad3 protein stability via inhibiting its ubiquitin-proteasomal degradation
por: Xing, Yingying, et al.
Publicado: (2015)